LOREEV XR FDA approval date
The FDA approved LOREEV XR on 27 Aug 2021.
- FDA approval date
- 27 Aug 2021
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as LORAZEPAM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2021-08-27Day | LOREEV XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA214826", "applicant_as_listed_by_fda": "ALMATICA", "brand_names": ["LOREEV XR"], "active_ingredients": ["LORAZEPAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210827", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |